Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
Overview
The aim of this study is 1) To describe the level and determinants of methotrexate adherence in patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) in the department of rheumatology in the Nîmes University Hospital
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: May 30, 2018
Clinical Trial Outcome Measures
Primary Measures
- Medication Adherence Measure= Morisky scale
- Time Frame: day 0
Participating in This Clinical Trial
Inclusion Criteria
- treated by methotrexate – patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) Exclusion Criteria:
- methotrexate for other diseases
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Cécile Gaujoux-Viala, MD,PhD, Principal Investigator, CHU Nîmes
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.